Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients

NCT04044131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Parkinson Disease

Interventions

DRUG: Metabolic Cofactor Supplementation
DRUG: Sorbitol

Sponsor

Istanbul Medipol University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]